ELMlab's schizophrenia [33 articles] Export

Recent papers added to ELMlab's library classified by the tag schizophrenia. You can also see everyone's schizophrenia.

	alpha-Adrenergic Receptor Function in Schizophrenia: Receptor Number, Cyclic Adenosine Monophosphate Production, Adenylate Cyclase Activity, and Effect of Drugs [My Copy] In Arch Gen Psychiatry, Vol. 40, No. 3. (1 March 1983), pp. 264-270. by Marian S. Kafka, Daniel P. van Kammen posted to schizophrenia prostaglandin platelets by ELMlab on 2009-12-09 20:12:36 as
	Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. [My Copy] Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 29, No. 11. (November 2004), pp. 2108-2114. by Andrea Giuffrida, F. Markus Leweke, Christoph W. Gerth, et al.Daniela Schreiber, Dagmar Koethe, Johannes Faulhaber, Joachim Klosterkötter, Daniele Piomelli posted to schizophrenia first-episode anandamide by ELMlab on 2009-12-06 22:37:10 as
	Orthomolecular Treatment for Schizophrenia: A Review (Part One) [My Copy] Journal of Orthomolecular Medicine, Vol. 23, No. 1. (2008), pp. 21-28. by Raymond J. Pataracchia posted to schizophrenia orthomolecular by ELMlab on 2009-08-20 20:52:08 as
	A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii. [My Copy] Schizophrenia research, Vol. 112, No. 1-3. (23 July 2009), pp. 198-199. by F. B. Dickerson, C. R. Stallings, J. J. Boronow, A. E. Origoni, R. H. Yolken posted to gondii schizophrenia toxoplasma by ELMlab on 2009-07-13 20:26:14 as
	The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. [My Copy] Schizophrenia research, Vol. 62, No. 3. (1 August 2003), pp. 251-258. by E. Messamore, W. F. Hoffman, A. Janowsky posted to schizophrenia by ELMlab on 2009-06-17 17:17:15 as
	N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. [My Copy] Biological psychiatry, Vol. 64, No. 5. (1 September 2008), pp. 361-368. by M. Berk, D. Copolov, O. Dean, et al.K. Lu, S. Jeavons, I. Schapkaitz, M. Anderson-Hunt, F. Judd, F. Katz, P. Katz, S. Ording-Jespersen, J. Little, P. Conus, M. Cuenod, K. Q. Do, A. I. Bush posted to orphan refractory schizophrenia by ELMlab on 2009-06-17 04:31:23 as
	Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. [My Copy] Neuropsychobiology, Vol. 59, No. 1. (2009), pp. 51-58. by B. H. Lee, Y. K. Kim posted to bdnf endophenotype schizophrenia by ELMlab on 2009-06-17 04:21:42 as
	Searching for the phenotypes of schizophrenia. [My Copy] Acta psychiatrica Scandinavica. Supplementum, Vol. 384 (1994), pp. 34-39. by R. L. Cromwell, I. J. Elkins, M. E. McCarthy, T. S. O'Neil posted to endophenotype nosology schizophrenia by ELMlab on 2009-06-09 21:41:10 as
	Is the concept of schizophrenia useful from an aetiological point of view? A selective review of findings and paradoxes. [My Copy] Acta psychiatrica Scandinavica. Supplementum, Vol. 384 (1994), pp. 17-25. by E. Kringlen posted to nosology schizophrenia by ELMlab on 2009-06-09 20:59:37 as
	The concept of schizophrenia: pro et contra. [My Copy] Epidemiologia e psichiatria sociale, Vol. 8, No. 4. (c 1999), pp. 242-247. by A. Jablensky posted to nosology schizophrenia by ELMlab on 2009-06-09 20:58:40 as
	Progressive brain volume loss during adolescence in childhood-onset schizophrenia. [My Copy] The American journal of psychiatry, Vol. 160, No. 12. (December 2003), pp. 2181-2189. by A. L. Sporn, D. K. Greenstein, N. Gogtay, et al.N. O. Jeffries, M. Lenane, P. Gochman, L. S. Clasen, J. Blumenthal, J. N. Giedd, J. L. Rapoport posted to endophenotype first-episode schizophrenia by ELMlab on 2009-06-09 20:39:56 as
	Erythrocyte sedimentation rate in patients with schizophrenia. [My Copy] Canadian journal of psychiatry. Revue canadienne de psychiatrie, Vol. 45, No. 10. (December 2000) by Y. Melamed, P. Sirota posted to endophenotype inflammatory schizophrenia by ELMlab on 2009-06-09 20:28:59 as
	Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double blind randomized placebo controlled treatment study [My Copy] Schizophrenia Bulletin, Vol. 33(suppl) (2007), pp. 418-419. by G. Amminger, M. R. Schaefer, K. Papageorgiou, et al.J. Becker, N. Mossaheb, S. M. Harrigan, P. D. Mcgorry, G. E. Berger posted to fatty first-episode schizophrenia by ELMlab on 2009-06-08 03:35:15 as
	Back to the future: predicting and reshaping the course of psychotic disorder. [My Copy] Archives of general psychiatry, Vol. 65, No. 1. (January 2008), pp. 25-27. by P. D. McGorry, A. R. Yung, A. Bechdolf, P. Amminger posted to schizophrenia by ELMlab on 2009-06-08 03:16:06 as
	Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. [My Copy] Drugs, Vol. 63, No. 5. (2003), pp. 493-512. by A. C. Altamura, F. Sassella, A. Santini, C. Montresor, S. Fumagalli, E. Mundo posted to clinical consta schizophrenia by ELMlab on 2009-06-08 01:45:52 as
	Could schizophrenia be reasonably explained by Dohan's hypothesis on genetic interaction with a dietary peptide overload? [My Copy] Progress in neuro-psychopharmacology & biological psychiatry, Vol. 20, No. 7. (October 1996), pp. 1083-1114. by K. L. Reichelt, A. R. Seim, W. H. Reichelt posted to gluten schizophrenia by ELMlab on 2009-06-08 00:58:24 as
	Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. [My Copy] Journal of internal medicine, Vol. 242, No. 5. (November 1997), pp. 421-423. by A. De Santis, G. Addolorato, A. Romito, et al.S. Caputo, A. Giordano, G. Gambassi, C. Taranto, R. Manna, G. Gasbarrini posted to gluten schizophrenia by ELMlab on 2009-06-08 00:48:28 as
	"Bread madness" revisited: screening for specific celiac antibodies among schizophrenia patients. [My Copy] European psychiatry : the journal of the Association of European Psychiatrists, Vol. 19, No. 5. (August 2004), pp. 311-314. by R. Peleg, Z. I. Ben-Zion, A. Peleg, et al.L. Gheber, M. Kotler, Z. Weizman, A. Shiber, A. Fich, Y. Horowitz, P. Shvartzman posted to gluten schizophrenia by ELMlab on 2009-06-08 00:46:52 as
	Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population. [My Copy] Schizophrenia bulletin (3 June 2009) by Nicola G. Cascella, Debra Kryszak, Bushra Bhatti, et al.Patricia Gregory, Deanna L. Kelly, Joseph P. Mc Evoy, Alessio Fasano, William W. Eaton posted to endophenotype gluten schizophrenia by ELMlab on 2009-06-08 00:11:11 as
	COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date. [My Copy] CNS drugs, Vol. 19, No. 10. (2005), pp. 805-819. by M. Riedel, M. Strassnig, M. J. Schwarz, N. Müller posted to celecoxib cox inflammatory schizophrenia by ELMlab on 2009-06-07 23:41:29 as
	Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. [My Copy] Schizophrenia research, Vol. 90, No. 1-3. (February 2007), pp. 179-185. by S. Akhondzadeh, M. Tabatabaee, H. Amini, S. A. Ahmadi Abhari, S. H. Abbasi, B. Behnam posted to celecoxib inflammatory schizophrenia by ELMlab on 2009-06-07 23:39:40 as
	Interactions between antiepileptic and antipsychotic drugs. [My Copy] Drug Saf, Vol. 29, No. 2. (2006), pp. 95-118. by F. M. Besag, D. Berry posted to anticonvulsants clinical drug-interactions epilepsy schizophrenia by ELMlab on 2009-06-07 08:02:46 as along with 1 person pseudopharm
	The role of selegiline in the treatment of negative symptoms associated with schizophrenia. [My Copy] The Annals of pharmacotherapy, Vol. 41, No. 5. (May 2007), pp. 851-856. by K. D. Fohey, R. Hieber, L. A. Nelson posted to refractory schizophrenia selegiline by ELMlab on 2009-06-07 07:44:56 as
	Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia. [My Copy] The American journal of psychiatry, Vol. 162, No. 2. (February 2005), pp. 388-390. by J. A. Bodkin, S. G. Siris, P. C. Bermanzohn, J. Hennen, J. O. Cole posted to refractory schizophrenia selegiline by ELMlab on 2009-06-07 07:38:52 as
	Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. [My Copy] Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 28, No. 8. (August 2003), pp. 1515-1520. by D. L. Garver, R. L. Tamas, J. A. Holcomb posted to endophenotype inflammatory schizophrenia by ELMlab on 2009-06-07 07:09:37 as
	Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. [My Copy] The Journal of clinical psychiatry, Vol. 61, No. 12. (December 2000) by D. L. Garver, J. A. Holcomb, J. D. Christensen posted to endophenotype schizophrenia by ELMlab on 2009-06-07 07:04:57 as
	A crossover study of allopurinol administration to a schizophrenic child. [My Copy] Journal of autism and childhood schizophrenia, Vol. 4, No. 3. (September 1974), pp. 231-240. by M. Coleman posted to allopurinol schizophrenia by ELMlab on 2009-06-06 21:58:32 as
	Possible case of allopurinol causing relapse of psychosis. [My Copy] Schizophrenia research, Vol. 93, No. 1-3. (July 2007) by R. Gomberg posted to allopurinol schizophrenia by ELMlab on 2009-06-06 21:56:18 as
	A double-blind trial of adjunctive allopurinol for schizophrenia. [My Copy] Schizophrenia research, Vol. 109, No. 1-3. (April 2009), pp. 66-69. by F. B. Dickerson, C. R. Stallings, A. E. Origoni, et al.A. Sullens, S. Khushalani, N. Sandson, R. H. Yolken posted to allopurinol schizophrenia by ELMlab on 2009-06-06 21:54:06 as
	A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia. [My Copy] The Journal of clinical psychiatry, Vol. 66, No. 2. (February 2005), pp. 213-219. by M. G. Brunstein, E. S. Ghisolfi, F. L. Ramos, D. R. Lara posted to allopurinol refractory schizophrenia by ELMlab on 2009-06-06 21:52:26 as
	Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. [My Copy] Progress in neuro-psychopharmacology & biological psychiatry, Vol. 29, No. 2. (February 2005), pp. 253-259. by S. Akhondzadeh, A. Safarcherati, H. Amini posted to allopurinol schizophrenia by ELMlab on 2009-06-06 21:49:14 as
	Allopurinol augmentation for poorly responsive schizophrenia. [My Copy] International clinical psychopharmacology, Vol. 16, No. 4. (July 2001), pp. 235-237. by D. R. Lara, M. G. Brunstein, E. S. Ghisolfi, M. I. Lobato, P. Belmonte-de-Abreu, D. O. Souza posted to allopurinol refractory schizophrenia by ELMlab on 2009-06-06 21:46:31 as
	Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia. [My Copy] The Annals of pharmacotherapy, Vol. 40, No. 12. (December 2006), pp. 2200-2204. by L. W. Buie, M. D. Oertel, S. O. Cala posted to allopurinol refractory schizophrenia by ELMlab on 2009-06-06 21:43:43 as

Note: You may cite this page as: http://www.citeulike.org/user/ELMlab/tag/schizophrenia

schizophrenia	33
allopurinol	13
trazodone	10
bipolar	8
endophenotype	7
refractory	6
gluten	4
nosology	4
lamotrigine	4
borderline	4
inflammatory	4
first-episode	3
celecoxib	3
consta	3
clinical	2
epilepsy	2
orphan	2
selegiline	2
tms	2
niacin	1
drug-interactions	1
arachidonic	1
bdnf	1
cocaine	1
stress	1
pgd2	1
toxoplasma	1
anticonvulsants	1
alcohol	1
writing	1
orthomolecular	1
anandamide	1
gondii	1
oxidative	1
fatty	1
prostaglandin	1
platelets	1
cox	1

ELMlab's schizophrenia [33 articles] Export

ELMlab's tags